---
title: "ThinkonSemi released its performance for the first half of the year, with a net profit attributable to the parent company of 48.8379 million yuan, a year-on-year increase of 925.55%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254177151.md"
description: "ThinkonSemi released its semi-annual report for 2025, with operating revenue of 209 million yuan, a year-on-year increase of 66.53%; net profit attributable to the parent company of 48.8379 million yuan, a year-on-year increase of 925.55%; net profit excluding non-recurring gains and losses of 47.9899 million yuan, a year-on-year increase of 1132.44%; basic earnings per share of 0.29 yuan"
datetime: "2025-08-22T12:39:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254177151.md)
  - [en](https://longbridge.com/en/news/254177151.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254177151.md)
generator: "portal-rs"
---

# ThinkonSemi released its performance for the first half of the year, with a net profit attributable to the parent company of 48.8379 million yuan, a year-on-year increase of 925.55%

According to the Zhitong Finance APP, ThinkonSemi (688233.SH) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 209 million yuan, a year-on-year increase of 66.53%. The net profit attributable to shareholders of the listed company was 48.8379 million yuan, a year-on-year increase of 925.55%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 47.9899 million yuan, a year-on-year increase of 1132.44%. The basic earnings per share were 0.29 yuan

### Related Stocks

- [688233.CN](https://longbridge.com/en/quote/688233.CN.md)

## Related News & Research

- [US Cocoa Futures (COCOA-F) Volatility Intensified on Sep 2: What to Watch](https://longbridge.com/en/news/297778138.md)
- [Air China GAAP EPS of -RMB 0.13, revenue of RMB 89.27B](https://longbridge.com/en/news/297480690.md)
- [Optomed unit Ubetec selected for Veikkaus gaming compliance contract worth EUR 0.9 million](https://longbridge.com/en/news/298042604.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)
- [Tezos to Launch Post-Quantum Testnet in September](https://longbridge.com/en/news/297946567.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**